4002 Stock Overview
Mouwasat Medical Services Company acquires, manages, operates, and maintains hospitals, medical centers, drug stores, and pharmacies in the Kingdom of Saudi Arabia.
No risks detected for 4002 from our risk checks.
Mouwasat Medical Services Competitors
Price History & Performance
|Historical stock prices|
|Current Share Price||ر.س198.00|
|52 Week High||ر.س259.40|
|52 Week Low||ر.س158.80|
|1 Month Change||-16.88%|
|3 Month Change||-7.04%|
|1 Year Change||9.39%|
|3 Year Change||125.00%|
|5 Year Change||147.19%|
|Change since IPO||1,277.39%|
Recent News & Updates
Returns At Mouwasat Medical Services (TADAWUL:4002) Appear To Be Weighed Down
What are the early trends we should look for to identify a stock that could multiply in value over the long term? One...
A Look At The Fair Value Of Mouwasat Medical Services Company (TADAWUL:4002)
Does the July share price for Mouwasat Medical Services Company ( TADAWUL:4002 ) reflect what it's really worth? Today...
|4002||SA Healthcare||SA Market|
Return vs Industry: 4002 underperformed the SA Healthcare industry which returned 19.3% over the past year.
Return vs Market: 4002 exceeded the SA Market which returned 2.4% over the past year.
|4002 Average Weekly Movement||4.9%|
|Healthcare Industry Average Movement||4.4%|
|Market Average Movement||4.5%|
|10% most volatile stocks in SA Market||7.3%|
|10% least volatile stocks in SA Market||2.8%|
Stable Share Price: 4002 is not significantly more volatile than the rest of SA stocks over the past 3 months, typically moving +/- 5% a week.
Volatility Over Time: 4002's weekly volatility (5%) has been stable over the past year.
About the Company
|1974||n/a||Nasser Sultan Al-Subaie||https://www.mouwasat.com|
Mouwasat Medical Services Company acquires, manages, operates, and maintains hospitals, medical centers, drug stores, and pharmacies in the Kingdom of Saudi Arabia. It operates a network of hospitals in Dammam, Jubail, Madinah, Khobar, Qatif, and Riyadh that provides a range of medical services. The company also operates skin care centers, which offer laser, cosmetic dermatological, reconstructive surgery, beauty, clinical dermatology, plastic surgery, weight loss, and other medical cosmetic services; a fertility center; and a clinic for bariatric surgery.
Mouwasat Medical Services Fundamentals Summary
|4002 fundamental statistics|
Is 4002 overvalued?See Fair Value and valuation analysis
Earnings & Revenue
|4002 income statement (TTM)|
|Cost of Revenue||ر.س1.20b|
Last Reported Earnings
Jun 30, 2022
Next Earnings Date
|Earnings per share (EPS)||5.81|
|Net Profit Margin||26.33%|
How did 4002 perform over the long term?See historical performance and comparison
1.4%Current Dividend Yield
Is 4002 undervalued compared to its fair value, analyst forecasts and its price relative to the market?
Valuation Score 3/6
Price-To-Earnings vs Peers
Price-To-Earnings vs Industry
Price-To-Earnings vs Fair Ratio
Below Fair Value
Significantly Below Fair Value
Key Valuation Metric
Which metric is best to use when looking at relative valuation for 4002?
Other financial metrics that can be useful for relative valuation.
|What is 4002's n/a Ratio?|
Price to Earnings Ratio vs Peers
How does 4002's PE Ratio compare to its peers?
|4002 PE Ratio vs Peers|
|Company||PE||Estimated Growth||Market Cap|
4004 Dallah Healthcare
4007 Al Hammadi Holding
4013 Dr. Sulaiman Al Habib Medical Services Group
4005 National Medical Care
4002 Mouwasat Medical Services
Price-To-Earnings vs Peers: 4002 is good value based on its Price-To-Earnings Ratio (34.1x) compared to the peer average (39.2x).
Price to Earnings Ratio vs Industry
How does 4002's PE Ratio compare vs other companies in the Asian Healthcare Industry?
Price-To-Earnings vs Industry: 4002 is expensive based on its Price-To-Earnings Ratio (34.1x) compared to the Asian Healthcare industry average (17.4x)
Price to Earnings Ratio vs Fair Ratio
What is 4002's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.
|Current PE Ratio||34.1x|
|Fair PE Ratio||n/a|
Price-To-Earnings vs Fair Ratio: Insufficient data to calculate 4002's Price-To-Earnings Fair Ratio for valuation analysis.
Share Price vs Fair Value
What is the Fair Price of 4002 when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.
Below Fair Value: 4002 (SAR198) is trading below our estimate of fair value (SAR276.65)
Significantly Below Fair Value: 4002 is trading below fair value by more than 20%.
Analyst Price Targets
What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?
Analyst Forecast: Target price is less than 20% higher than the current share price.
Discover undervalued companies
How is Mouwasat Medical Services forecast to perform in the next 1 to 3 years based on estimates from 9 analysts?
Future Growth Score4/6
Future Growth Score 4/6
Earnings vs Savings Rate
Earnings vs Market
High Growth Earnings
Revenue vs Market
High Growth Revenue
Forecasted annual earnings growth
Earnings and Revenue Growth Forecasts
Analyst Future Growth Forecasts
Earnings vs Savings Rate: 4002's forecast earnings growth (13.6% per year) is above the savings rate (8.9%).
Earnings vs Market: 4002's earnings (13.6% per year) are forecast to grow faster than the SA market (-2.8% per year).
High Growth Earnings: 4002's earnings are forecast to grow, but not significantly.
Revenue vs Market: 4002's revenue (10.4% per year) is forecast to grow faster than the SA market (-5.3% per year).
High Growth Revenue: 4002's revenue (10.4% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: 4002's Return on Equity is forecast to be high in 3 years time (23.7%)
Discover growth companies
How has Mouwasat Medical Services performed over the past 5 years?
Past Performance Score3/6
Past Performance Score 3/6
Growing Profit Margin
Earnings vs Industry
Historical annual earnings growth
Earnings and Revenue History
Quality Earnings: 4002 has high quality earnings.
Growing Profit Margin: 4002's current net profit margins (26.3%) are lower than last year (27.7%).
Past Earnings Growth Analysis
Earnings Trend: 4002's earnings have grown by 14.6% per year over the past 5 years.
Accelerating Growth: 4002's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.
Earnings vs Industry: 4002 had negative earnings growth (-2%) over the past year, making it difficult to compare to the Healthcare industry average (-2.5%).
Return on Equity
High ROE: 4002's Return on Equity (22.8%) is considered high.
Discover strong past performing companies
How is Mouwasat Medical Services's financial position?
Financial Health Score6/6
Financial Health Score 6/6
Short Term Liabilities
Long Term Liabilities
Financial Position Analysis
Short Term Liabilities: 4002's short term assets (SAR1.4B) exceed its short term liabilities (SAR782.9M).
Long Term Liabilities: 4002's short term assets (SAR1.4B) exceed its long term liabilities (SAR801.9M).
Debt to Equity History and Analysis
Debt Level: 4002's net debt to equity ratio (31.9%) is considered satisfactory.
Reducing Debt: 4002's debt to equity ratio has reduced from 37.2% to 34% over the past 5 years.
Debt Coverage: 4002's debt is well covered by operating cash flow (59%).
Interest Coverage: 4002's interest payments on its debt are well covered by EBIT (107.8x coverage).
Discover healthy companies
What is Mouwasat Medical Services's current dividend yield, its reliability and sustainability?
Dividend Score 3/6
Cash Flow Coverage
Current Dividend Yield
Dividend Yield vs Market
|Mouwasat Medical Services Dividend Yield vs Market|
|Company (Mouwasat Medical Services)||1.4%|
|Market Bottom 25% (SA)||2.0%|
|Market Top 25% (SA)||4.7%|
|Industry Average (Healthcare)||1.6%|
|Analyst forecast in 3 Years (Mouwasat Medical Services)||1.8%|
Notable Dividend: 4002's dividend (1.39%) isn’t notable compared to the bottom 25% of dividend payers in the SA market (2.05%).
High Dividend: 4002's dividend (1.39%) is low compared to the top 25% of dividend payers in the SA market (4.67%).
Stability and Growth of Payments
Stable Dividend: 4002's dividends per share have been stable in the past 10 years.
Growing Dividend: 4002's dividend payments have increased over the past 10 years.
Earnings Payout to Shareholders
Earnings Coverage: With its reasonably low payout ratio (47.3%), 4002's dividend payments are well covered by earnings.
Cash Payout to Shareholders
Cash Flow Coverage: With its high cash payout ratio (169.6%), 4002's dividend payments are not well covered by cash flows.
Discover strong dividend paying companies
How experienced are the management team and are they aligned to shareholders interests?
Nasser Sultan Al-Subaie (67 yo)
Mr. Nasser Sultan Al-hammad Al-subaie serves as the Chief Executive Officer and Vice Chairman of Al-Mouwasat Medical Services Company. Mr. Al-subaie holds a Certificate in managing health organizations fro...
Who are the major shareholders and have insiders been buying or selling?
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
|Owner Type||Number of Shares||Ownership Percentage|
Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.
|Ownership||Name||Shares||Current Value||Change %||Portfolio %|
Mouwasat Medical Services Company's employee growth, exchange listings and data sources
- Name: Mouwasat Medical Services Company
- Ticker: 4002
- Exchange: SASE
- Founded: 1974
- Industry: Health Care Facilities
- Sector: Healthcare
- Implied Market Cap: ر.س19.820b
- Shares outstanding: 100.00m
- Website: https://www.mouwasat.com
- Mouwasat Medical Services Company
- Destect 71 - King Fahad Road
- PO Box 282
- Saudi Arabia
|Ticker||Exchange||Primary Security||Security Type||Country||Currency||Listed on|
|4002||SASE (Saudi Arabian Stock Exchange)||Yes||Ordinary Shares||SA||SAR||Sep 2009|
Company Analysis and Financial Data Status
|Data||Last Updated (UTC time)|
|Company Analysis||2022/09/29 00:00|
|End of Day Share Price||2022/09/29 00:00|
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.